ME00059B - Oksidekahidronaftalen modulatori hm74 - Google Patents

Oksidekahidronaftalen modulatori hm74

Info

Publication number
ME00059B
ME00059B MEP-2008-170A MEP2008170A ME00059B ME 00059 B ME00059 B ME 00059B ME P2008170 A MEP2008170 A ME P2008170A ME 00059 B ME00059 B ME 00059B
Authority
ME
Montenegro
Prior art keywords
oxydecahydronaphthalene
modulators
oxidase
molecules
formula
Prior art date
Application number
MEP-2008-170A
Other languages
English (en)
Inventor
Anne Minnich
Theresa Kuntzweiler
Haifeng Eishingdrelo
Michael Angelastro
Stephan Henke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ME00059B publication Critical patent/ME00059B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Ćelije domaćina u kojima se pojavljuje HM74 se koriste za dobijanje molekula sličnih oksidekalinu sa aktivnošću agoniste koje imaju sledeću strukturu (formula I).
MEP-2008-170A 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74 ME00059B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74
EP05713199A EP1718293A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
ME00059B true ME00059B (me) 2010-06-10

Family

ID=34910747

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-170/08A MEP17008A (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-170/08A MEP17008A (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Country Status (21)

Country Link
US (2) US7264937B2 (me)
EP (1) EP1718293A1 (me)
JP (1) JP2007526917A (me)
KR (1) KR101145693B1 (me)
CN (1) CN1929833A (me)
AR (1) AR047708A1 (me)
AU (1) AU2005216878B2 (me)
BR (1) BRPI0507916A (me)
CA (1) CA2556757C (me)
CR (1) CR8537A (me)
EC (1) ECSP066776A (me)
IL (1) IL177106A (me)
MA (1) MA28368A1 (me)
ME (2) MEP17008A (me)
NO (1) NO20064214L (me)
RS (1) RS20060472A (me)
RU (1) RU2006133539A (me)
TN (1) TNSN06235A1 (me)
TW (1) TWI354552B (me)
WO (1) WO2005082352A1 (me)
ZA (1) ZA200606687B (me)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CA2589483C (en) 2004-12-03 2013-10-29 Schering Corporation Substituted piperazines as cb1 antagonists
BRPI0706623A2 (pt) * 2006-01-18 2011-04-12 Schering Corp moduladores de receptor canabinóide
WO2008130616A2 (en) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines as cb1 modulators
MX2010000334A (es) * 2007-06-28 2010-04-22 Intervet Int Bv Piperazinas sustituidas como antagonistas de cannabinoides 1.
CN101790521A (zh) * 2007-06-28 2010-07-28 英特维特国际股份有限公司 作为cb1拮抗剂的取代哌嗪

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
AU7966098A (en) * 1997-06-12 1998-12-30 Smithkline Beecham Corporation Hm74a receptor
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
CR8537A (es) 2007-03-05
BRPI0507916A (pt) 2007-07-10
ECSP066776A (es) 2006-11-16
NO20064214L (no) 2006-09-18
RS20060472A (en) 2008-11-28
ZA200606687B (en) 2008-02-27
IL177106A (en) 2012-03-29
CA2556757A1 (en) 2005-09-09
AU2005216878B2 (en) 2010-06-17
CN1929833A (zh) 2007-03-14
IL177106A0 (en) 2006-12-10
US20080045586A1 (en) 2008-02-21
AR047708A1 (es) 2006-02-08
AU2005216878A1 (en) 2005-09-09
EP1718293A1 (en) 2006-11-08
WO2005082352A1 (en) 2005-09-09
KR20060127982A (ko) 2006-12-13
US20050187263A1 (en) 2005-08-25
TW200539864A (en) 2005-12-16
US7264937B2 (en) 2007-09-04
CA2556757C (en) 2011-05-03
RU2006133539A (ru) 2008-03-27
JP2007526917A (ja) 2007-09-20
MEP17008A (en) 2010-06-10
KR101145693B1 (ko) 2012-05-25
TWI354552B (en) 2011-12-21
MA28368A1 (fr) 2006-12-01
TNSN06235A1 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
ATE471324T1 (de) Triazolophthalazine
ME00059B (me) Oksidekahidronaftalen modulatori hm74
BRPI0606379A2 (pt) triazolftalazinas
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
CO6470854A2 (es) Variantes de celulasa con expresión, actividad y/o estabilidad mejoradas, y uso de las mismas
ATE544767T1 (de) Triazoloä4,5-düpyramidinderivate und deren verwendung als purinrezeptorantagonisten
DE602008004397D1 (de) Neuartige Elektroden
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20064237L (no) Furosemide modulatorer for HM74
EA201170051A1 (ru) Гетероциклическое соединение и его применение
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
BRPI0502534A (pt) Gel perfluoroelastomérico, processo para formar géis perfluoroelastoméricos, perfluoroelastÈmeros reticuláveis e curados, artigos manufaturados, e, uso de gel
BRPI0508471A8 (pt) compostos de hidróxi-6-fenilfenantidinas substituídas por difluoroetóxi, composição farmacêutica e uso para a produção dos mesmos
DE602007006541D1 (de) Verwendung von wassergräsern als träger für erdbodenlose kultivierung und so gebildeter träger
EA200800144A1 (ru) МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
SV2010003755A (es) Nuevos derivados de (piperazinilo con enlaces puente)-1-alcanona y su utilizacion como inhibidores de p75
WO2006104751A3 (en) Methods and compositions for modulating rho-mediated gene transcription
AR073871A1 (es) Intermediario de fulvestran
AR051506A1 (es) Polipeptidos con actividad antimicrobiana y polinucleotidos que los codifican